Anglo-Swedish pharmaceutical firm AstraZeneca has agreed to pay a $510 million fine to settle a case alleging that it illegally marketed an anti-psychotic drug, the US justice department has confirmed.
The firm's US division agreed to the fine for marketing the the anti-psychotic drug Seroquel for so-called "off-label" uses not included in the drug's approved product label, the Justice Department said.
US authorities contended that AstraZeneca illegally marketed Seroquel for uses never approved by the Food and Drug Administration (FDA) such as aggression, Alzheimer's disease, anger management, anxiety, attention deficit hyperactivity disorder, bipolar maintenance, dementia, depression, mood disorder, post-traumatic stress disorder, and sleeplessness.
Read more . . .
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment